Newmont Corporation
NEMLast close · Oct 16, 2026118.60+2.81 (+2.43%)
Market cap$125.0B
6 firms' latest targets, last 90 days: median $142.00 ($110.00–$154.00), 20% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-16 | CIBC | $154.00 | ▼ 9% | +30% |
| 2026-09-09 | Bernstein | $144.00 | — | +21% |
| 2026-08-24 | Raymond James | $140.00 | ▲ 26% | +18% |
| 2026-08-12 | Scotiabank | $149.00 | ▲ 1% | +26% |
| 2026-08-03 | Argus Research | $110.00 | — | -7% |
| 2026-07-28 | Barclays | $124.00 | ▼ 1% | +5% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $11.8B | -1% | -$2.97 | — | est. $11.3B+4% | est. $1.51 | 6 |
| 2024reported | $18.7B | +58% | $2.92 | — | est. $18.2B+3% | est. $3.09 | 8 |
| 2025reported | $22.7B | +21% | $6.39 | +119% | est. $22.1B+3% | est. $6.56 | 10 |
| 2026 | $26.7B | +18% | $9.33 | +42% | $26.3B–$27.1B | $8.96–$9.85 | 12 |
| 2027 | $28.7B | +8% | $10.43 | +12% | $28.0B–$29.3B | $8.72–$12.80 | 12 |
| 2028 | $29.7B | +4% | $11.79 | +13% | $24.0B–$38.7B | $7.55–$17.31 | 15 |
| 2029 | $29.9B | +1% | $11.51 | -2% | $27.2B–$35.9B | $10.13–$14.48 | 10 |
| 2030 | $24.7B | -18% | $10.59 | -8% | $22.4B–$29.6B | $9.32–$13.32 | 7 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.